Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

CMML2AML: Machine-learning discovery of co-mutations predictive of blast transformation in chronic myelomonocytic leukemia

Blood (2025) 146 (Supplement 1): 3844.

https://doi.org/10.1182/blood-2025-3844

Published: 2025

Journal Articles

Spatial multiomics reveal a critical role for TIM4-expressing macrophages in blast transformation of chronic myelomonocytic leukemia

Abhishek Mangaonkar, Justin Boysen, Terra Lasho, Christy Finke, Jenna Fernandez, Jose Villasboas Bisneto, Mehrdad Hefazi Torghabeh, Pankaj Pradeep, Will Sherman, Christy Trussoni, Tamas Ordog, Maha Rahim, Alejandro Ferrer, Kaaren Reichard, Mrinal Patnaik

Blood (2025) 146 (Supplement 1): 3831.

https://doi.org/10.1182/blood-2025-3831

Published: 2025

Journal Articles

Myeloproliferative neoplasm driver mutations (JAK2/CALR/MPL) in chronic myelomonocytic leukemia are associated with an increased risk of blast transformation

Muhammad Yousuf, Saubia Fathima, Priyansh Faldu, Ali Alsugair, Abiola Bolarinwa, Andrew Cannon, Terra Lasho, Abhishek Mangaonkar, Kaaren Reichard, Rong He, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

Blood (2025) 146 (Supplement 1): 2067.

https://doi.org/10.1182/blood-2025-2067

Published: 2025

Journal Articles

Myeloproliferative neoplasms-unclassifiable (MPN-U): A carefully curated series of 30 Mayo Clinic patients

Rania Abdelaziz, Priyansh Faldu, Saubia Fathima, Kaaren Reichard, Rong He, Cinthya Mendoza Zepeda, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

Blood (2025) 146 (Supplement 1): 7314.

https://doi.org/10.1182/blood-2025-7314

Published: 2025

Journal Articles

Identification of red cell distribution width as a key predictor of leukemic transformation in polycythemia vera and essential thrombocythemia: A machine learning approach involving 10,560 cases

Lior Rokach, Tamar Tadmor, Rania Abdelaziz, Guy Melamed, Priyansh Faldu, Hilel Alapi, Muhammad Yousuf, Merry Nakhleh, Animesh Pardanani, Kaaren Reichard, Rong He, Naseema Gangat, Ayalew Tefferi

Blood (2025) 146 (Supplement 1): 2021.

https://doi.org/10.1182/blood-2025-2021

Published: 2025

Journal Articles

DIPSS-R: A revised age-agnostic clinical risk model for chronic phase primary myelofibrosis

Ayalew Tefferi, Alessandro Vannucchi, Yassin Bashir, Ahmed Abdelrheem, Maymona Abdelmagid, Giuseppe Gaetano Loscocco, leonardo Signori, Giulia Borgi, Valentina Boldrini, Kebede Begna, Kaaren Reichard, Rong He, Cinthya Mendoza, Tiziano Barbui, Francesco Passamonti, Animesh Pardanani, Naseema Gangat, Paola Guglielmelli

Blood (2025) 146 (Supplement 1): 84.

https://doi.org/10.1182/blood-2025-84

Published: 2025

Journal Articles

Fetal hemoglobin dysregulation in inherited and acquired bone marrow failure syndromes

Blood (2025) 146 (Supplement 1): 6750.

https://doi.org/10.1182/blood-2025-6750

Published: 2025

Journal Articles

Disease stage-specific mutational landscape in essential thrombocythemia and prognostic correlates: A Mayo Clinic study of 500 NGS-informative cases

Merry Nakhleh, Rong He, Priyansh Faldu, David Viswanatha, Kaaren Reichard, Cinthya Mendoza, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

Blood (2025) 146 (Supplement 1): 3799.

https://doi.org/10.1182/blood-2025-3799

Published: 2025

Journal Articles

Clinical NGS detection of TP53 mutations in chronic phase primary myelofibrosis: Comparative analyses of genotype and prognosis

Blood (2025) 146 (Supplement 1): 3798.

https://doi.org/10.1182/blood-2025-3798

Published: 2025

Journal Articles

Post-FDA approval experience with momelotinib in JAK inhibitor-naïve myelofibrosis: Focus on anemia response and treatment-emergent nephropathy and peripheral neuropathy

Ayalew Tefferi, Maymona Abdelmagid, Jeanne Palmer, Aref Al-Kali, Cecilia Arana Yi, Aasiya Matin, Hassan Alkhateeb, Talha Badar, Yassin Bashir, Kaaren Reichard, Rong He, Animesh Pardanani, Naseema Gangat

Blood (2025) 146 (Supplement 1): 3791.

https://doi.org/10.1182/blood-2025-3791

Published: 2025

Journal Articles

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

Blood (2025) 146 (Supplement 1): 2087.

https://doi.org/10.1182/blood-2025-2087

Published: 2025

Journal Articles

Validation of blast and blast-mol risk models in chronic myelomonocytic leukemia: Mayo-humanitas collaborative project involving 1,101 patients

Saubia Fathima, Muhammad Yousuf, Priyansh Faldu, Ali Alsugair, Clifford Csizmar, Merry Nakhleh, Abhishek Mangaonkar, Animesh Pardanani, Luca Lanino, Alessia Campagna, Giulia Maggioni, Kaaren Reichard, Rong He, Naseema Gangat, Mrinal Patnaik, Matteo Della Porta, Ayalew Tefferi

Blood (2025) 146 (Supplement 1): 2077.

https://doi.org/10.1182/blood-2025-2077

Published: 2025

Journal Articles

The need for re-induction based on D14-residual acute myeloid leukemia in patients achieving complete remission predicts higher relapse rate and inferior post-remission survival

Blood (2025) 146 (Supplement 1): 1605.

https://doi.org/10.1182/blood-2025-1605

Published: 2025

Journal Articles

Interplay between mutant DNMT3A and UBA1 worsens survival through altered inflammatory and metabolic pathways

Blood (2025) 146 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2025-3191

Published: 2025

Journal Articles

Upfront therapy with allogeneic hematopoietic stem cell transplantation versus DNA methyltransferase inhibitors in patients with vexas syndrome: A comparative matched cohort efficacy analysis of 39 patients

Blood (2025) 146 (Supplement 1): 981.

https://doi.org/10.1182/blood-2025-981

Published: 2025

Journal Articles

MAPS-R: International consensus classification-guided revision of the mayo alliance prognostic system for systemic mastocytosis

Ayalew Tefferi, Fnu Aperna, Mahesh Kumar, Maymona Abdelmagid, Joseph Butterfield, Thanai Pongdee, Cecilia Arana Yi, Daniel Arber, Attilio Orazi, Dong Chen, Kaaren Reichard, Naseema Gangat, Animesh Pardanani

Blood (2025) 146 (Supplement 1): 2017.

https://doi.org/10.1182/blood-2025-2017

Published: 2025

Journal Articles

CSF3R-mutated chronic neutrophilic leukemia: A two-center study of 44 consecutive patients

Abiola Bolarinwa, Natasha Szuber, Janick Caron-L'Ecuyer, Aref Al-Kali, William Hogan, Mithun Shah, James Foran, Talha Badar, Kaaren Reichard, Rong He, Naseema Gangat, Cinthya Mendoza, Michelle Elliott, Animesh Pardanani, Ayalew Tefferi

Blood (2025) 146 (Supplement 1): 2013.

https://doi.org/10.1182/blood-2025-2013

Published: 2025

Journal Articles

Venous and arterial thrombosis in patients with VEXAS syndrome

Blood (2024) 143 (21): 2190–2200.

https://doi.org/10.1182/blood.2023022329

Published: 2024

Includes: Supplemental data

Journal Articles

Spectrum of clonal hematopoiesis in VEXAS syndrome

Blood (2023) 142 (3): 244–259.

https://doi.org/10.1182/blood.2022018774

Published: 2023

Includes: Supplemental data

Journal Articles

CD123 Immunostaining in Systemic Mastocytosis: Differential Expression in Disease Subgroups and Potential Prognostic Value

Animesh Pardanani, MBBS, PhD, Kaaren Reichard, MD, Darci Zblewski, CNP, Ramy Abdelrahman, M.B.,B.Ch., Emnet Wassie, MD, William G. Morice, MD PhD, Christopher L. Brooks, PhD, Curtis A. Hanson, MD, Ayalew Tefferi, MD, Dong Chen, MD PhD

Blood (2015) 126 (23): 2802.

https://doi.org/10.1182/blood.V126.23.2802.2802

Published: 2015

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CMML2AML: Machine-learning discovery of co-mutations predictive of blast transformation in chronic myelomonocytic leukemia

Spatial multiomics reveal a critical role for TIM4-expressing macrophages in blast transformation of chronic myelomonocytic leukemia

Myeloproliferative neoplasm driver mutations (JAK2/CALR/MPL) in chronic myelomonocytic leukemia are associated with an increased risk of blast transformation

Myeloproliferative neoplasms-unclassifiable (MPN-U): A carefully curated series of 30 Mayo Clinic patients

Identification of red cell distribution width as a key predictor of leukemic transformation in polycythemia vera and essential thrombocythemia: A machine learning approach involving 10,560 cases

DIPSS-R: A revised age-agnostic clinical risk model for chronic phase primary myelofibrosis

Fetal hemoglobin dysregulation in inherited and acquired bone marrow failure syndromes

Disease stage-specific mutational landscape in essential thrombocythemia and prognostic correlates: A Mayo Clinic study of 500 NGS-informative cases

Clinical NGS detection of TP53 mutations in chronic phase primary myelofibrosis: Comparative analyses of genotype and prognosis

Post-FDA approval experience with momelotinib in JAK inhibitor-naïve myelofibrosis: Focus on anemia response and treatment-emergent nephropathy and peripheral neuropathy

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

Validation of blast and blast-mol risk models in chronic myelomonocytic leukemia: Mayo-humanitas collaborative project involving 1,101 patients

The need for re-induction based on D14-residual acute myeloid leukemia in patients achieving complete remission predicts higher relapse rate and inferior post-remission survival

Interplay between mutant DNMT3A and UBA1 worsens survival through altered inflammatory and metabolic pathways

Upfront therapy with allogeneic hematopoietic stem cell transplantation versus DNA methyltransferase inhibitors in patients with vexas syndrome: A comparative matched cohort efficacy analysis of 39 patients

MAPS-R: International consensus classification-guided revision of the mayo alliance prognostic system for systemic mastocytosis

CSF3R-mutated chronic neutrophilic leukemia: A two-center study of 44 consecutive patients

Venous and arterial thrombosis in patients with VEXAS syndrome

Spectrum of clonal hematopoiesis in VEXAS syndrome

CD123 Immunostaining in Systemic Mastocytosis: Differential Expression in Disease Subgroups and Potential Prognostic Value

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only